Precision Medicine in Breast Medicine: A Real Change for Thousands of Women
Gianluca Franceschini, Director of the Integrated Center for Senology and the Breast Surgery Unit of the Gemelli Polyclinic, posted on LinkedIn:
”Precision medicine in Breast Medicine: a real change for thousands of women.
As Director of the Integrated Breast Center of the Gemelli Polyclinic, I see every day how scientific innovation can concretely transform the treatment path of our patients.
- Genomic tests, such as Oncotype DX, are rewriting the therapeutic approach to hormone-responsive breast cancers, which account for more than 70% of diagnoses.
- These tools help us understand who really benefits from chemotherapy and who can be safely treated with hormone therapy alone.
The result?
Thousands of women can avoid unnecessarily heavy treatments without reducing the effectiveness of treatment.
It is a decisive step forward in terms of quality of life, sustainability and personalization of treatment.
We continue to work – together with colleagues in Precision Medicine and National Research Groups – to further expand their use, even in the pre-operative phase, and to define increasingly personalized therapeutic strategies.
Precision medicine is not the future: it is already here. And it’s changing the lives of our patients, one treatment decision at a time.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Alessandra Fabi
Gianluca Franceschini ”
Read more here.
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment